Best General Drug Manufacturer Stocks to Buy Now (2025)Top general drug manufacturer stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best general drug manufacturer stocks to buy now. Learn More.
Industry: Drug Manufacturers - Gene...
A
General Drug Manufacturers is Zen Rated A and is the 7th ranked industry out of 145 stock market industries
Learn how the Zen Ratings work| Ticker | Company | Price | 1d % | 1w % | 1m % | 3m % | 6m % | 1y % | 3y % | 5y % | 10y % | 52-week High | 52-week Low | % off 52-week High | % off 52-week Low | Beta | Volume | Vol 1d % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| JNJ | JOHNSON & JOHNSON | $156.31 | 0.26% | 0.60% | -5.75% | 2.25% | -2.68% | 8.11% | -12.50% | 4.18% | 57.57% | $169.99 | $140.68 | 8.05% | 11.11% | 0.27 | 9,572,802 | 82.45% |
| GILD | GILEAD SCIENCES INC | $106.54 | 2.24% | 0.15% | -4.92% | 9.89% | 20.67% | 63.40% | 76.65% | 26.83% | 6.00% | $119.96 | $62.07 | 11.19% | 71.64% | 0.41 | 9,617,287 | 25.78% |
| BMY | BRISTOL MYERS SQUIBB CO | $50.20 | 1.99% | 3.44% | -17.69% | -15.12% | -4.67% | 14.25% | -33.14% | -17.45% | -21.23% | $63.33 | $39.35 | 20.73% | 27.57% | 0.34 | 15,929,560 | -20.08% |
| NVS | NOVARTIS AG | $113.49 | 0.04% | 3.05% | 1.80% | 8.34% | 3.26% | 16.84% | 29.48% | 33.94% | 11.48% | $120.92 | $96.06 | 6.14% | 18.14% | 0.36 | 2,501,333 | -1.66% |
| AZN | ASTRAZENECA PLC | $71.79 | 0.11% | 4.79% | -2.33% | 0.77% | -1.43% | -5.39% | 8.07% | 37.32% | 109.67% | $87.68 | $61.24 | 18.12% | 17.23% | 0.42 | 4,056,549 | -48.78% |
| GSK | GSK PLC | $39.85 | 2.26% | 7.62% | 2.87% | 12.70% | 7.67% | -3.84% | -28.71% | -24.22% | -30.92% | $45.93 | $31.72 | 13.23% | 25.65% | 0.37 | 8,015,979 | -2.91% |
| ABBV | ABBVIE INC | $195.10 | 0.82% | 10.19% | -6.88% | 11.07% | -3.18% | 19.96% | 31.94% | 137.35% | 201.73% | $218.66 | $153.58 | 10.77% | 27.03% | 0.39 | 8,369,866 | 25.46% |
| LLY | ELI LILLY & CO | $898.95 | 1.55% | 8.38% | 8.84% | 9.20% | 6.15% | 15.09% | 210.45% | 481.32% | 1,150.80% | $972.53 | $677.09 | 7.57% | 32.77% | 0.59 | 4,296,144 | 75.04% |
| GRFS | GRIFOLS SA | $6.95 | -1.84% | -3.34% | -2.25% | 0.58% | -20.75% | 8.09% | -35.59% | -65.76% | -56.30% | $9.96 | $5.79 | 30.22% | 20.03% | 0.71 | 1,014,063 | 96.07% |
| BIIB | BIOGEN INC | $121.08 | 0.76% | 2.46% | -11.52% | -17.20% | -33.17% | -43.64% | -41.60% | -59.21% | -67.62% | $238.00 | $110.04 | 49.13% | 10.04% | 0.75 | 1,524,112 | 51.91% |
| SNY | SANOFI | $54.95 | 2.29% | 3.64% | -0.92% | 1.48% | 2.81% | 11.62% | 3.56% | 17.34% | 8.70% | $60.12 | $45.80 | 8.59% | 19.98% | 0.35 | 1,687,068 | -20.66% |
| PFE | PFIZER INC | $24.41 | 2.61% | 9.02% | -3.67% | -9.29% | -14.41% | -4.72% | -49.50% | -36.37% | -28.06% | $31.54 | $20.92 | 22.61% | 16.71% | 0.42 | 53,827,184 | -45.38% |
| AMGN | AMGEN INC | $290.92 | 0.82% | 4.69% | -6.62% | 2.43% | -7.80% | 6.20% | 25.98% | 21.61% | 84.23% | $346.85 | $253.30 | 16.13% | 14.85% | 0.47 | 2,606,474 | 21.36% |
| MRK | MERCK & CO INC | $85.20 | 0.58% | 8.20% | -5.08% | -13.90% | -18.73% | -34.07% | -2.80% | 7.39% | 43.05% | $134.63 | $75.93 | 36.72% | 12.21% | 0.32 | 13,795,658 | -26.63% |
| OGN | ORGANON & CO | $12.93 | -1.75% | 12.53% | -13.16% | -19.04% | -27.89% | -30.52% | -59.69% | N/A | N/A | $23.10 | $10.45 | 44.03% | 23.73% | 0.80 | 5,404,394 | -3.22% |
| SCLX | SCILEX HOLDING CO | $4.74 | 2.82% | 16.75% | -45.50% | -69.22% | -85.62% | -84.13% | -98.67% | N/A | N/A | $80.50 | $3.60 | 94.11% | 31.67% | 0.28 | 504,142 | 72.48% |
| AMRN | AMARIN CORP PLC | $10.76 | 4.16% | 3.86% | 20.06% | -7.50% | -10.66% | -41.58% | -80.29% | -92.93% | -71.98% | $20.60 | $7.08 | 47.77% | 51.98% | 1.08 | 75,636 | 19.12% |
| MIRA | MIRA PHARMACEUTICALS INC | $1.16 | 3.57% | 25.95% | 18.37% | -7.94% | -47.27% | 36.47% | N/A | N/A | N/A | $5.01 | $0.51 | 76.85% | 127.45% | 1.78 | 490,869 | 1.39% |
General Drug Manufacturer Stocks FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.